We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Novacyt S.a. | LSE:NCYT | London | Ordinary Share | FR0010397232 | EUR1/15TH (CDI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-1.40 | -2.24% | 61.00 | 61.00 | 63.80 | 61.00 | 61.00 | 61.00 | 23,058 | 16:35:02 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
In Vitro,in Vivo Diagnostics | 22.49M | -25.73M | - | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
25/2/2020 13:13 | The Chinese can do it in 15 minutes. | moneymachine2 | |
25/2/2020 13:13 | how long will it take to reach all the brokers in the uk?? | datait2 | |
25/2/2020 13:11 | CODX late to the game and 6 hours test. Better than nothing but no competition for NCYT 2 hour 99.99% approved tester. | tidy 2 | |
25/2/2020 13:09 | so CODX has beaten NCYT in the race it seems. wonder what will happen next???? | datait2 | |
25/2/2020 13:08 | By David Wagner Investing.com - If the coronavirus crisis weighs on almost all sectors, we can note some companies whose activity is tailor-made to shine in this kind of situation. For example, faced with the hope of developing vaccines, several biotechnology companies have indeed posted incredible progress since the start of the year. Suppliers of protective masks are also on the front line. But there is a French action which undoubtedly benefited more than all the others from the coronavirus. It is the French Novacyt (PA: ALNOV ), which produces medical tests, including one recently launched concerning the coronavirus. After having started the year at 0.4510 Euros, and therefore under the not very glorious status of "penny stock", the action indeed marked a peak at 2.6750 Euros on February 17, ie an increase of almost 500%. The company announced on that date that its molecular diagnostic division, Primerdesign, launched its CE-Mark molecular test for the clinical detection of the new coronavirus (COVID-19), stressing that thanks to CE marking, the test can be used directly by laboratories and hospitals to test patients. Following its peak on February 17, the stock posted a strong correction, but market panic over the spread of the coronavirus outside of China yesterday caused a rebound of 23.26% yesterday, and the stock posted a further increase of 4.40 % today, posting a gain of almost 270% since the start of the year. If the coronavirus epidemic degenerates into a global pandemic, hundreds of millions of tests could be used, which could largely fuel the rise in the title. Today alone, South Korea has announced plans to test 200,000 people, and it is expected that this kind of massive operation will escalate as the epidemic spreads outside of China. Overall, we can therefore expect that, for the moment, the bad news about the coronavirus will remain good news for Novacyt. | likya123 | |
25/2/2020 13:07 | ncyt dropping cos they have been beaten imo by CODX stock. | datait2 | |
25/2/2020 13:06 | And they are second in the queue | tidy 2 | |
25/2/2020 13:05 | yes that bit 'South Korea to test 200,000 people' is a glimpse into the future. | andrbea | |
25/2/2020 13:04 | CODX stock pre sold 150,000 kits and approval imminent. the americans going wild for CODX stock. | datait2 | |
25/2/2020 13:02 | Sicily confirms first case of Corona virus | mikeavvinti | |
25/2/2020 13:02 | Fuji, those countries that hang around in their preparedness will not be thanked by their public.. | still waiting | |
25/2/2020 13:00 | CODX stock has virus results in 45 minutes. | datait2 | |
25/2/2020 12:58 | In their 2018 annual report I read they sell testing consumables for between #$%$10 to #$%$50 and kits at around #$%$5k taken from yahoo finance b board chat. | datait2 | |
25/2/2020 12:55 | Because the virus is spreading so fast around the world that NCYT has so many urgent activities such as endless inquiries for their test kit to deal with they do not have enough time to update the market. It is also possible they are dealing with so many different news they are preparing a full package at once. I have a feeling we will get multiple updates on various sales/inquiries and approvals (FDA, China, Europe) in a form of a package in one RNS. | fuji99 | |
25/2/2020 12:53 | anyone got the link to the post at the w/e about number of tests and price target. may need to review. | still waiting | |
25/2/2020 12:51 | By David WagnerInvesting.com - If the coronavirus crisis weighs on almost all sectors, we can note some companies whose activity is tailor-made to shine in this kind of situation.For example, faced with the hope of developing vaccines, several biotechnology companies have indeed posted incredible progress since the start of the year. Suppliers of protective masks are also on the front line.But there is a French action which undoubtedly benefited more than all the others from the coronavirus. It is the French Novacyt (PA: ALNOV ), which produces medical tests, including one recently launched concerning the coronavirus.After having started the year at 0.4510 Euros, and therefore under the not very glorious status of "penny stock", the action indeed marked a peak at 2.6750 Euros on February 17, ie an increase of almost 500%.The company announced on that date that its molecular diagnostic division, Primerdesign, launched its CE-Mark molecular test for the clinical detection of the new coronavirus (COVID-19), stressing that thanks to CE marking, the test can be used directly by laboratories and hospitals to test patients.Following its peak on February 17, the stock posted a strong correction, but market panic over the spread of the coronavirus outside of China yesterday caused a rebound of 23.26% yesterday, and the stock posted a further increase of 4.40 % today, posting a gain of almost 270% since the start of the year.If the coronavirus epidemic degenerates into a global pandemic, hundreds of millions of tests could be used, which could largely fuel the rise in the title.Today alone, South Korea has announced plans to test 200,000 people, and it is expected that this kind of massive operation will escalate as the epidemic spreads outside of China.Overall, we can therefore expect that, for the moment, the bad news about the coronavirus will remain good news for Novacyt. | tez123 | |
25/2/2020 12:50 | BREAKING: Croatia confirms first coronavirus case | tickboo | |
25/2/2020 12:50 | 5 times sales ratio is average, 10 times is max, so what are sales expected compared to £95 mill cap. | datait2 | |
25/2/2020 12:49 | US prepares for possible coronavirus pandemic, WHO officials say Iran outbreak 'worrisome'https://w | tidy 2 | |
25/2/2020 12:48 | instead of posting about school kids or hotels, why dont you post facts about rivals to this stock, projected net profits after tax and depreciation. then you can see if it worth £95 million. | datait2 | |
25/2/2020 12:46 | Sky News Breaking @SkyNewsBreak · 2m Cransley School in Northwich has temporarily closed after some pupils showed "flu-like symptoms" on a ski-trip to Lombardy | sweepie2 | |
25/2/2020 12:38 | Reports from China show workers running low on safety supplies including garments and masks | andrbea | |
25/2/2020 12:32 | This for health. Altn for gold. Both doing very nicely.. sell oil. | gregpeck7 | |
25/2/2020 12:26 | not sure about corona, but this datait virus is replicating itself, 5 copies in a row.. | still waiting |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions